| DC Field | Value | Language |
|---|
| dc.contributor.author | Puchenkova, O. A. | - |
| dc.contributor.author | Soldatov, V. O. | - |
| dc.contributor.author | Deykin, A. V. | - |
| dc.contributor.author | Korokin, M. V. | - |
| dc.contributor.author | Pokrovskiy, M. V. | - |
| dc.date.accessioned | 2023-03-23T07:00:17Z | - |
| dc.date.available | 2023-03-23T07:00:17Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.citation | Cytokines in abdominal aortic aneurysm: master regulators with clinical application / O.A. Puchenkova [et al.] // Biomarker Insights. - 2022. - Vol.17.-P. 1-16. - Doi: 10.1177/11772719221095676. - Refer.: p. 13-16. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/52349 | - |
| dc.description.abstract | Abdominal aortic aneurysm (AAA) is a potentially life-threatening disorder with a mostly asymptomatic course where the abdominal aorta is weakened and bulged. Cytokines play especially important roles (both positive and negative) among the molecular actors of AAA development. All the inflammatory cascades, extracellular matrix degradation and vascular smooth muscle cell apoptosis are driven by cytokines | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | abdominal aortic aneurysm | ru |
| dc.subject | cytokines | ru |
| dc.subject | inflammation | ru |
| dc.subject | TGF-β | ru |
| dc.subject | IL-6 | ru |
| dc.title | Cytokines in abdominal aortic aneurysm: master regulators with clinical application | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
